Search hospitals
>
New York
>
Rochester
University of Rochester
Claim this profile
Rochester, New York 14618
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Brain Tumor
1134 reported clinical trials
66 medical researchers
Summary
University of Rochester is a medical facility located in Rochester, New York. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Lymphoma, Brain Tumor and other specialties. University of Rochester is involved with conducting 1,134 clinical trials across 1,374 conditions. There are 66 research doctors associated with this hospital, such as Paul M. Barr, Yuhchyau Chen, Angela R. Girvin, and Craig A. Mullen.
Area of expertise
Cancer
University of Rochester has run 91 trials for Cancer. Some of their research focus areas include:
Lung Cancer
University of Rochester has run 80 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Paul M. Barr
University of Rochester
7 years of reported clinical research
Yuhchyau Chen
University of Rochester
6 years of reported clinical research
Angela R. Girvin
University of Rochester
8 years of reported clinical research
Craig A. Mullen
University of Rochester
8 years of reported clinical research
Clinical Trials running at University of Rochester
Lung Cancer
Skin Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Cancer
Kidney Cancer
Brain Tumor
Ovarian Cancer
Testicular cancer
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Rochester?
University of Rochester is a medical facility located in Rochester, New York. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Lymphoma, Brain Tumor and other specialties. University of Rochester is involved with conducting 1,134 clinical trials across 1,374 conditions. There are 66 research doctors associated with this hospital, such as Paul M. Barr, Yuhchyau Chen, Angela R. Girvin, and Craig A. Mullen.
Where is University of Rochester located?
The University of Rochester Medical Center is located at 601 Elmwood Ave, Rochester, NY 14620, on its campus. Multiple parking options are available, including a six-floor ramp garage connected to Strong Memorial Hospital, Golisano Children’s Hospital, and Wilmot Cancer Center.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Rochester Medical Center, including Strong Memorial Hospital and Highland Hospital: - Contact the Financial Assistance Officer at (585) 784-8889 or (800) 257-7049 for insurance verification, Medicaid assistance, community outreach, financial counseling, and case management. - To apply, submit an application with four consecutive paystubs, Social Security income, pension information, unemployment or workers' compensation award letters, or other proof of household gross income to: Financial Assistance Officer, Strong Memorial Hospital, 601 Elmwood Avenue – Box 888, Rochester, NY 14642. - For more details, visit Highland Hospital's financial assistance page or Strong Memorial Hospital's financial assistance page for guidelines and FAQs.
What insurance does University of Rochester accept?
The University of Rochester accepts a wide range of insurance plans, including but not limited to Aetna, Beacon Health Options, CIGNA, Excellus BlueCross and BlueShield, Fidelis Care, Humana, MVP Health Care, TRICARE, UnitedHealthcare, and Wellcare by Fidelis Care Medicare Plans. UR Medicine also contracts with most major health insurance carriers. Patients are advised to contact their insurance company to confirm access to health care services at UR Medicine locations.
What awards or recognition has University of Rochester received?
The University of Rochester Medical Center (URMC) is a leading institution in biomedical research, receiving over $1.3 billion in funding over the past five years. The UR CTSI offers seed funding for innovative clinical and translational research projects, with grants from $10,000 to $200,000. This initiative supports researchers at all career stages, promoting the advancement of medical science and the improvement of human health.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.